Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126817651 | 12681765 | 1 | I | 20160809 | 20160824 | 20160824 | EXP | CA-VALIDUS PHARMACEUTICALS LLC-CA-2016VAL002478 | VALIDUS | PERRI G-A, GROSSMAN D, KHOSRAVANI H, GORDON M. DIGOXIN FOR THE CONTROL OF CONGESTIVE HEART FAILURE SYMPTOMS IN PALLIATIVE CARE. ANNALS OF LONG-TERM CARE: CLINICAL CARE AND AGING. 2015;23 (8):29-32 | 72.00 | YR | M | Y | 0.00000 | 20160824 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126817651 | 12681765 | 1 | PS | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 20 MG, BID | U | 16273 | 20 | MG | |||||||
| 126817651 | 12681765 | 2 | SS | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | 12.5 MG, QD | Y | 0 | 12.5 | MG | ||||||||
| 126817651 | 12681765 | 3 | SS | CARVEDILOL. | CARVEDILOL | 1 | 3.25 MG, BID | U | 0 | 3.25 | MG | ||||||||
| 126817651 | 12681765 | 4 | SS | METOLAZONE. | METOLAZONE | 1 | 2.5 MG, TWICE A WEEK | Y | 0 | 2.5 | MG | ||||||||
| 126817651 | 12681765 | 5 | SS | RAMIPRIL. | RAMIPRIL | 1 | 2.5 MG, QD | Y | 0 | 2.5 | MG | ||||||||
| 126817651 | 12681765 | 6 | SS | HYDROMORPHONE HYDROCHLORIDE. | HYDROMORPHONE HYDROCHLORIDE | 1 | Oral | 0.3 MG, EVERY 4 HOURS | U | 0 | .3 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126817651 | 12681765 | 1 | Product used for unknown indication |
| 126817651 | 12681765 | 2 | Product used for unknown indication |
| 126817651 | 12681765 | 3 | Product used for unknown indication |
| 126817651 | 12681765 | 4 | Product used for unknown indication |
| 126817651 | 12681765 | 5 | Product used for unknown indication |
| 126817651 | 12681765 | 6 | Dyspnoea |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126817651 | 12681765 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126817651 | 12681765 | Blood creatinine increased | |
| 126817651 | 12681765 | Blood potassium increased | |
| 126817651 | 12681765 | Blood sodium decreased | |
| 126817651 | 12681765 | Chronic kidney disease | |
| 126817651 | 12681765 | Creatinine renal clearance decreased | |
| 126817651 | 12681765 | Hypotension | |
| 126817651 | 12681765 | Off label use | |
| 126817651 | 12681765 | Somnolence |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |